|
|
| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Diabetes Risk Panel with Score
Test CodeCPT Codes
82947, 83036, 80061
Includes
Hemoglobin A1c
Total Cholesterol, HDL Cholesterol, Triglycerides, Non-HDL and Calculated Components
8 Year Diabetes Risk
If Triglyceride is >400 mg/dL, Direct LDL will be performed at an additional charge (CPT code(s): 83721).
Preferred Specimen
Patient Preparation
If a cholesterol measurement is to be performed along with Triglycerides, but not part of a lipid panel, then the patient should be fasting 9-12 hours prior to collection. If the cholesterol is ordered as part of a lipid panel, then a fasting sample is not required.
The assay manufacturer Beckman Coulter advises: "N-Acetyl Cysteine (NAC), when administered in therapeutic concentrations (for the treatment of acetaminophen overdose), has been determined to interfere with assays for cholesterol and uric acid" where "NAC interference may lead to falsely low results." According to Beckman Coulter, the NAC interference should be insignificant by 12 hours after completion of the initial loading dose of an IV infusion treatment regimen consisting of an initial loading dose of 150 mg/kg administered over 1 hour, a second dose of 50 mg/kg administered over 4 hours and a third dose of 100 mg/kg administered over 16 hours.
Minimum Volume
Instructions
Age: Years
Gender: M (for male) or F (for female)
Transport Temperature
Specimen Stability
Room temperature: 48 hours
Refrigerated: 7 days
Frozen: 28 days
Whole blood
Room temperature: 7 days
Refrigerated: 7 days
Frozen: 6 months
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Methodology
Turbidimetric Inhibition Immunoassay • Spectrophotometry (SP)
Setup Schedule
Reference Range
Clinical Significance

